KANUMA 2 mg/mL (Sebelipase alfa INJECTION, SOLUTION, CONCENTRATE) 2 mg/mL

KANUMA 2 mg/mL is an enzyme replacement therapy used to manage a rare genetic disorder. This intravenous solution is designed to address specific metabolic needs, offering targeted support for affected individuals.

Strength

2 mg/mL

Pack Size

1 VIAL, GLASS in 1 CARTON (25682-007-01) / 10 mL in 1 VIAL, GLASS

Manufacturer / TM Owner

Alexion Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

KANUMA 2 mg/mL is primarily used for the treatment of a specific lysosomal storage disorder. This medication works by replacing the deficient enzyme, helping to break down certain fats that can build up in the body. Patients often seek this therapy to manage symptoms associated with this rare condition, aiming to improve overall quality of life.

Side Effects

Common effects of KANUMA 2 mg/mL may include reactions at the injection site, such as redness or swelling. Some individuals might experience flu-like symptoms, including fever or chills, shortly after administration. These effects are generally mild and temporary, but any persistent or severe reactions should be discussed with a healthcare provider.

Precautions & Warnings

KANUMA 2 mg/mL should be handled with care, ensuring proper storage and administration as directed. Patients with a history of severe allergic reactions to similar therapies should exercise caution. It is important to follow the prescribed dosage and administration guidelines to minimize potential risks.

Avoid Interactions

KANUMA 2 mg/mL may interact with other medications, particularly those that affect the immune system or blood clotting. Patients should inform their healthcare provider about all current medications, including over-the-counter drugs and supplements, to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.

Frequently Asked Questions

KANUMA 2 mg/mL is used to treat a specific lysosomal storage disorder by replacing a deficient enzyme.

KANUMA 2 mg/mL is administered intravenously, typically in a clinical setting.

Common side effects may include injection site reactions and flu-like symptoms.

Patients should consult their healthcare provider before combining KANUMA 2 mg/mL with other medications.

KANUMA 2 mg/mL should be stored as directed by the healthcare provider, typically in a refrigerator.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.